Who Owns MTNB?

Matinas BioPharma Holdings, Inc. — Institutional Ownership & 13F Holdings

$0.61

-0.00 (-0.59%)

Market Cap

$3.4M

Shares Outstanding

5,553,651

Institutional Holders

24

Total Inst. Value

$144K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$30K59,725
2BlackRock, Inc.$26K49,650
3GEODE CAPITAL MANAGEMENT, LLC$23K46,741
4Sargent Investment Group, LLC$21K41,800
5SUSQUEHANNA INTERNATIONAL GROUP, LLP$13K25,610
6RENAISSANCE TECHNOLOGIES LLC$12K22,370
7TWO SIGMA SECURITIES, LLC$11K20,974
8STATE STREET CORP$7K15,322
9UBS Group AG$8531,640
10Tower Research Capital LLC (TRC)$5761,108

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold MTNB?

As of Q1 2025, 24 institutional investors report holding MTNB (Matinas BioPharma Holdings, Inc.) in their 13F filings.

Which hedge fund owns the most MTNB?

The largest institutional holder of MTNB is VANGUARD GROUP INC with $30K in shares.

Are institutions buying or selling MTNB?

This quarter, 5 institutions opened new positions in MTNB and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.